At Curative Biotech, our unique business model coupled with our deep industry leadership experience enables us to build a pipeline of first in class drugs with accelerated development pathways to address the unmet medical needs of patients.
ABOUT US
We Focus on Identifying, Acquiring and Developing Disease Modifying Therapeutic Drug Candidates with a Concentration on Rare Disease Indications
Pipeline
We currently have development assets in three therapeutic areas:
Our programs are currently focused on orphan indications; however, the mechanisms of action we are targeting will likely allow us to expand the use of these drugs in the future to non-orphan indications.
Degenerative Eye Disease
Neuro Oncology
Infectious Disease
